Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

130.55
+1.110.86%
Volume:1.68M
Turnover:219.39M
Market Cap:19.13B
PE:12.91
High:131.13
Open:129.04
Low:128.82
Close:129.44
Loading ...

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-04-01

Reuters
·
02 Apr

Organon Acquires Tofidence for Intravenous Infusion in US

MT Newswires Live
·
01 Apr

Organon & Co - to Pay Tiered Royalties and Milestone Payments to Biogen

THOMSON REUTERS
·
01 Apr

Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years

Simply Wall St.
·
01 Apr

Biogen - Final Process for Ec Decision on Lecanemab’s Marketing Authorisation Application Underway

THOMSON REUTERS
·
01 Apr

Biogen Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
01 Apr

Is the Future Bleak for SAVA Stock Following Another Setback?

Zacks
·
31 Mar

Biogen Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
29 Mar

Biogen’s Favorable Outlook: Navigating Regulatory Challenges and Safety Advantages Justify Buy Rating

TIPRANKS
·
28 Mar

EU medicines regulator rejects Eli Lilly's Alzheimer's drug

Reuters
·
28 Mar

Lilly adds Alzheimer's to online offerings

Reuters
·
27 Mar

IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi

Zacks
·
27 Mar

SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study

Zacks
·
26 Mar

Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
26 Mar

Biogen Signs Lease for New Global HQ in Cambridge, Massachusetts

MT Newswires Live
·
24 Mar

BRIEF-Biogen Announces Plans For New Global Headquarters And Innovation Hub In Kendall Square

Reuters
·
24 Mar

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

THOMSON REUTERS
·
24 Mar

Biogen Inc - to Relocate Cambridge-Based Employees to New Site in 2028

THOMSON REUTERS
·
24 Mar

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

GlobeNewswire
·
24 Mar

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

StockStory
·
24 Mar